| 6th Jul 2015 7:00 am |
RNS |
Notice of Announcement of 2015 Interim Results |
| 29th Jun 2015 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 1st Jun 2015 7:00 am |
RNS |
Savolitinib preliminary Phase Ib data presented |
| 13th May 2015 7:00 am |
RNS |
Fruquintinib results trigger payments from Lilly |
| 30th Apr 2015 7:00 am |
RNS |
Total Voting Rights |
| 24th Apr 2015 12:40 pm |
RNS |
Result of AGM |
| 22nd Apr 2015 11:23 am |
RNS |
Director/PDMR Shareholding |
| 16th Apr 2015 1:19 pm |
RNS |
Director's Shareholding |
| 13th Apr 2015 8:07 am |
RNS |
Director's Shareholding |
| 8th Apr 2015 8:18 am |
RNS |
Directors' Shareholding |
| 1st Apr 2015 3:48 pm |
RNS |
Directors Shareholding |
| 1st Apr 2015 2:32 pm |
RNS |
Exercise of Options |
| 30th Mar 2015 7:00 am |
RNS |
Trial of fruquintinib achieves primary endpoint |
| 23rd Mar 2015 7:00 am |
RNS |
Notice of AGM |
| 18th Mar 2015 7:08 am |
RNS |
Notification of Major Interest in Shares |
| 6th Mar 2015 7:06 am |
RNS |
Patient enrolment completion for Phase II study |
| 26th Feb 2015 7:00 am |
RNS |
Final Results |
| 29th Jan 2015 7:00 am |
RNS |
Distribution Agreement for Seroquel in China |
| 26th Jan 2015 7:00 am |
RNS |
Notice of Results |
| 31st Dec 2014 7:00 am |
RNS |
Total Voting Rights |
| 29th Dec 2014 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 15th Dec 2014 7:00 am |
RNS |
Initiation of fruquintinib Phase III study |
| 31st Oct 2014 7:03 am |
RNS |
Total Voting Rights |
| 7th Oct 2014 7:00 am |
RNS |
Drug R&D Update Briefing |
| 1st Oct 2014 7:00 am |
RNS |
Co-promotion agreement with Merck Serono |
| 19th Sep 2014 9:13 am |
RNS |
Holding(s) in Company |
| 21st Aug 2014 7:00 am |
RNS |
Patient enrolment in Phase II study completed |
| 13th Aug 2014 7:00 am |
RNS |
HMPL-004 Interim Analysis |
| 29th Jul 2014 7:00 am |
RNS |
Interim Results |
| 30th Jun 2014 7:00 am |
RNS |
Blocklisting Interim Review |
| 30th Jun 2014 7:00 am |
RNS |
Total Voting Rights |
| 26th Jun 2014 7:00 am |
RNS |
Notice of Results |
| 25th Jun 2014 7:00 am |
RNS |
Chi-Med Refinancing of Existing Loan Facility |
| 18th Jun 2014 7:00 am |
RNS |
Start of Phase I clinical trial with HMPL-523 |
| 5th Jun 2014 7:00 am |
RNS |
Initiation of fruquintinib Phase II study |
| 4th Jun 2014 1:52 pm |
RNS |
Director's Shareholding |
| 3rd Jun 2014 3:23 pm |
RNS |
Exercise of Options |
| 30th May 2014 9:10 am |
RNS |
Gains rights to six prescription drug products |
| 23rd May 2014 7:00 am |
RNS |
Initiation of Phase II Study in Renal Cancer |
| 22nd May 2014 7:00 am |
RNS |
Phase I data to be presented at ASCO |
